Unveiling the secret of cellular metamorphosis: the crucial role of EndMT mechanisms in COVID-19-induced pulmonary fibrosis
Inflammopharmacology · 2025
DOI: 10.1007/s10787-025-01927-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2025. Verfasst von Xin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First People's Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu, 61020…. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Fibrosis, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan province, International Science and Technology Cooperation Project of Chengdu, Youth Innovation Project of Sichuan Medical Association.
Abstract (Originalsprache)
The COVID-19 pandemic has resulted in several long-term complications, with COVID-19-induced pulmonary fibrosis being a significant concern. Despite increasing recognition, the mechanisms underlying its development, effective treatment strategies, and long-term outcomes remain poorly understood. Emerging research highlights the direct impact of SARS-CoV-2 on vascular endothelial cells, identifying endothelial-mesenchymal transition (EndMT) as a key factor in the progression of COVID-19-induced pulmonary fibrosis. However, there is a notable lack of comprehensive reviews addressing the link between EndMT and COVID-19-induced pulmonary fibrosis. This review seeks to fill that gap by providing an in-depth analysis of the relationship between EndMT and fibrosis, examining relevant risk factors and molecular pathways. Our findings offer critical insights that could inform the development of targeted anti-fibrotic therapies aimed at mitigating COVID-19-related pulmonary fibrosis. Ultimately, this review aims to advance understanding of the role of EndMT in pulmonary fibrosis and to guide future research and treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The First People's Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu, 610200, China.
- State Key Laboratory of Biotherapy, Sichuan University, Chengdu, 610064, China.
- School of Professional Studies, Columbia University, New York, NY, 10027, USA.
- Department of Neurology Medicine, The Aviation Industry Corporation of China (AVIC) 363 Hospital, Chengdu, 610041, China.
- Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610064, China. zhanglanlan@wchscu.edu.cn.
Förderung
- Natural Science Foundation of Sichuan province
- International Science and Technology Cooperation Project of Chengdu
- Youth Innovation Project of Sichuan Medical Association
- Chengdu Medical Research Projects
Zitieren
APA
Zhang, X., Tong, X., Hou, R., Wang, P., Mo, Y., & Zhang, L. (2025). Unveiling the secret of cellular metamorphosis: the crucial role of EndMT mechanisms in COVID-19-induced pulmonary fibrosis. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01927-3
Vancouver
Zhang X, Tong X, Hou R, Wang P, Mo Y, Zhang L. Unveiling the secret of cellular metamorphosis: the crucial role of EndMT mechanisms in COVID-19-induced pulmonary fibrosis. Inflammopharmacology. 2025. doi:10.1007/s10787-025-01927-3
BibTeX
@article{Zhang2025,
author = {Zhang, Xin and Tong, Xia and Hou, Ruijie and Wang, Pengbo and Mo, Yan and Zhang, Lanlan},
title = {Unveiling the secret of cellular metamorphosis: the crucial role of EndMT mechanisms in COVID-19-induced pulmonary fibrosis},
journal = {Inflammopharmacology},
year = {2025},
doi = {10.1007/s10787-025-01927-3}
}
EUVIMED